Schedule 13D ownership disclosure

Akari Therapeutics Plc

Security class unavailable · CUSIP: 00972G108

Event date: 2023-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
22.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-045574
Form type
SC 13D/A
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Apr 14, 2023
Reporting period
Mar 31, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub